LMP1, a well-recognized initiator of oncogenic pathway in EBV-infected NPC, has been shown to activate the NFκB, JNKs, JAK3, MAPKs signaling pathway to promote NPC cell proliferation, radioresistance and immune resistance [20–22]. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.